Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04599478 · ClinicalTrials.gov registry record · Phase 2
Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
A Phase 2 study of Loss-of-control Eating and Obesity/Overweight, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT04599478 is a Phase 2 study of Loss-of-control Eating and Obesity/Overweight that is actively recruiting participants, run by Yale University. The registered enrollment target is 160 participants, above the 55-participant average among 3 other Loss-of-control Eating trials with a reported enrollment target (191% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04599478, a Phase 2 study of Loss-of-control Eating and Obesity/Overweight, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the effectiveness of behavioral and pharmacologic treatments, alone and in combination, for the treatment of loss-of-control eating and weight following bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in combination with combination naltrexone/bupropion medication.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Naltrexone and Bupropion medication
- BEHAVIORAL Behavioral Weight Loss
Study Locations (1)
Connecticut
- Yale Department of Psychiatry - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2027-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04599478
The ClinicalTrials.gov registry entry for NCT04599478 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 55-participant average among 3 other Loss-of-control Eating trials with a reported enrollment target (191% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Loss-of-control Eating appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04599478 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04599478 about?
NCT04599478 is a clinical study titled "Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)". This study will compare the effectiveness of behavioral and pharmacologic treatments, alone and in combination, for the treatment of loss-of-control eating and weight following bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in combination with combination nal...
What is the current status of trial NCT04599478?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2021-06-29. Estimated completion is 2027-01.
What conditions does trial NCT04599478 study?
This clinical trial studies the following conditions: Loss-of-control Eating, Obesity/Overweight.
What interventions are being tested in trial NCT04599478?
The interventions under investigation include: Placebo (OTHER), Naltrexone and Bupropion medication (DRUG), Behavioral Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT04599478?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04599478 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Loss-of-control Eating
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
ACTIVE NOT RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
ACTIVE NOT RECRUITING · Phase 2
-
Responsive Neurostimulation For Loss Of Control Eating
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.